English | 2023 | PDF | 148 MB | 950 Pages
Bin Yu, Ning Li, Caiyun Fu, 9780443186110, 978-0443186110, 978-0-443-18611-0, B0CCL2H51N, 0443186111, 044318612X, 9780443186127, 978-0443186127
Privileged Scaffolds in Drug Discovery
is the most complete and up-to-date work in the area. Covering a wide
range of privileged structures, it is a perfect reference for scientists
involved in targeted drug development.
The editors recruited epserts
from several prestigious Chinese institutions to cover the areas of
antiviral drugs, chalcone, pyrimidine, (benz)imidazoles, natural
product-derived privileged scaffolds, N-Sulfonyl carboxamides, kinase
inhibitors, antitumor molecules, antineurodegenerative drugs, triazoles,
oxazolidinone, indole and indoline scaffolds, tigliane diterpenoids,
peptide and peptide-based drugs, quassinoids, and others including
pseudonatural products, macrocycles, stable peptides and
peptidomimetics. The book also explores scaffolds in drug molecules
approved in recent years.
Privileged Scaffolds in Drug Discovery is a
complete reference for researchers in drug discovery and organic
synthesis, in academic and corporate settings, who are investigating
privileged structures upon which to base new drugs. Researchers in
medicinal chemistry and chemical biology will also find the contents of
this book valuable.
- Provides wide coverage of privileged scaffolds in new drug discovery
- Includes complex and diverse natural product scaffolds
- Covers applications to peptides and peptide-based drugs
